ID   CHP-1
AC   CVCL_6E27
DR   Wikidata; Q54813259
RX   PubMed=26762899;
RX   PubMed=30268330;
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Jack Russell Terrier; VBO=VBO_0200724.
DI   NCIt; C128122; Canine prostate carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 10
//
RX   PubMed=26762899; DOI=10.1111/vco.12199;
RA   Azakami D., Nakahira R., Kato Y., Michishita M., Kobayashi M.,
RA   Onozawa E., Bonkobara M., Kobayashi M., Takahashi K., Watanabe M.,
RA   Ishioka K., Sako T., Ochiai K., Omi T.;
RT   "The canine prostate cancer cell line CHP-1 shows over-expression of
RT   the co-chaperone small glutamine-rich tetratricopeptide
RT   repeat-containing protein alpha.";
RL   Vet. Comp. Oncol. 15:557-562(2017).
//
RX   PubMed=30268330; DOI=10.1016/j.tvjl.2018.09.001;
RA   Miyamoto R., Kurita S., Tani H., Ikeda T., Ishizaka M., Saima H.,
RA   Kobayashi M., Tamura K., Bonkobara M.;
RT   "Canine squamous cell carcinoma cell lines with high expression of
RT   survivin are sensitive to survivin inhibitor YM155.";
RL   Vet. J. 240:31-36(2018).
//